The Institut Curie, founded in 1909 by the renowned scientist Marie Curie, is recognized as one of the leading cancer research centers in France and worldwide. It combines a world-renowned research center with a state-of-the-art hospital complex, bringing together more than 3,700 researchers, doctors, and healthcare professionals. The institute pursues three main missions: care, research, and teaching, which enable it to play a key role in advancing knowledge and treatments against cancer.
The Institut Curie is distinguished by its significant contributions in various fields of medical and scientific research, particularly in the fight against cancer. It is at the forefront of innovation in the use of artificial intelligence (AI) to improve cancer diagnosis and treatment. For example, the Institute has collaborated with Ibex Medical Analytics to develop Galen Breast, an AI solution capable of accurately detecting different types of breast cancer, demonstrating high precision in identifying pathological features.
Furthermore, the Institute is at the forefront of personalized medicine approaches, notably through collaborations with technological leaders such as Google. Together, they have launched research programs to develop deep learning methods to analyze complex transcriptomic and epigenetic data. These efforts aim to characterize tumor heterogeneity and predict treatment resistance, thus contributing to the advent of a new era of targeted therapies.
The Institut Curie recently signed a strategic partnership with Google to deepen the understanding and treatment of female cancers, with a particular focus on triple-negative breast cancer. This partnership leverages the power of AI to analyze anatomical pathology and medical imaging data, with the goal of identifying new biomarkers and predicting treatment responses.
Another large-scale project is the collaboration with Spotlight Medical, a spin-off of the Institute, which uses AI to offer personalized cancer treatments. Spotlight Medical focuses on developing clinical tests that leverage genomic, clinical, and imaging data to guide oncologists in selecting the most appropriate treatments.
The Institut Curie positions itself as a leader in the application of artificial intelligence technologies in the health sector. Its collaborations with technology giants like Google and innovative startups like Owkin and Spotlight Medical illustrate its ability to integrate technological advancements into cancer research and treatment. The Institute also plays an active role in initiatives such as the Health Data Hub, which aims to facilitate access to health data to accelerate biomedical research.
Among recent news, the signing of a strategic framework agreement with Janssen France to accelerate innovation in oncology stands out. This agreement aims to strengthen multi-pathology research and develop new collaborations in immuno-oncology, precision medicine, and radiotherapy.
Moreover, the Institute has been involved in launching the Health Data Hub, a national health data sharing platform that facilitates health research by providing access to anonymized databases. One of the flagship projects associated with this initiative is DEEP.PISTE, which evaluates the contribution of artificial intelligence in organized breast cancer screening.
In conclusion, the Institut Curie continues to distinguish itself through its commitment to technological and scientific innovation, playing a crucial role in improving cancer treatments by integrating artificial intelligence and cutting-edge data into its clinical and research practices.
L’institut Curie, acteur de référence de la lutte contre le cancer, associe un centre de recherche de renommée internationale et un ensemble hospitalier de pointe qui prend en charge tous les cancers y compris les plus rares. Fondé en 1909 par Marie Curie, l’Institut Curie rassemble plus de 3 400 chercheurs, médecins et soignants autour de ses 3 missions : soins, recherche et enseignement.
Fondation privée reconnue d’utilité publique habilitée à recevoir des dons et des legs, l’Institut Curie peut, grâce au soutien de ses donateurs, accélérer les découvertes et ainsi améliorer les traitements et la qualité de vie des malades.
Autre
9 articles liés à cet acteur
For several years, Institut Curie and Google have been combining their expertise to advance research and treatments to fight cancer. This collaboratio...
On July 4, the Institut Curie, France's leading cancer center, announced the signing of a five-year strategic framework agreement with Janssen France,...
In early April, Anap (the French national agency for supporting the performance of healthcare and medico-social institutions) announced the launch of...
In 2019, the strategic contract of the health industries and technologies sector was signed by several ministries: Health, Higher Education, Economy &...
On May 18, the University of Paris Sciences & Lettres (PSL) launched the second edition of its COFUND "Artificial Intelligence for the Sciences" c...
Carried by the PSL University, the doctoral program "Artificial Intelligence for the Sciences" launches a call for applications open until February 26...
The Institut Curie and Google announced on Thursday 10 December the launch of a joint research programme on artificial intelligence (AI). They will wo...
The Institut Curie announced this week its research partnership with Ibex Medical Analytics to improve breast cancer diagnosis using artificial intell...
This week's Unicancer Innovation Award Ceremony was held at the National Convention of Cancer Centres (NCCC). For its sixth edition, Unicancer focused...
